Company Overview of Restoragen Inc.
Restoragen, Inc. develops and produces recombinant peptide hormone therapies for age-related diseases. Its peptide therapies restore and regulate the body's endocrine hormone systems. The company’s products include hormone Glucagon-like peptide-1, which is used as a therapy for type II diabetes, obesity, glucose intolerance, and other metabolic conditions. Restoragen, Inc. also offers Growth Hormone Releasing Factor that stimulates the pituitary gland to release growth hormones for the treatment of osteoporosis, muscle frailty, and congestive heart failure. Restoragen, Inc. was formerly known as BioNebraska, Inc. The company was founded in 1989 and is headquartered in Lincoln, Nebraska.
5701 South 34th Street
Lincoln, NE 68516
Founded in 1989
Key Executives for Restoragen Inc.
Similar Private Companies By Industry
|Csl Us Inc||United States|
|Advanced Targeting Systems, Inc.||United States|
|Melinta Therapeutics, Inc.||United States|
|Samara Innovations, LLC||United States|
|Ibis Biosciences, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Restoragen Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.